Objective To investigate the role of phosphatase and tensin homology deleted on chromosome ten ( PTEN) in a rat model of carbon tetrachloride ( CCl4) -induced liver fibrosis and the molecular mechanism of action of qi-tonifying and blood-activating prescription in regulating PTEN and inhibiting liver fibrosis. Methods A total of 27 male Wistar rats were randomly divided into three groups, with 9 rats in each group. The rats in liver fibrosis group were treated with CCl4 to establish a model of liver fibrosis, and those in qi-tonifying and blood-activating prescription group were also treated with CCl4 to establish a model and then given a self-made qi-tonifying and blood-activating prescription containing Astragalus membranaceus, Salvia miltiorrhiza, and poria. The rats in the control group were given intraperitoneally injected olive oil. HE staining, Masson staining, and immunohistochemical staining of collagen type I alpha 1 ( Col1 A1) and collagen type Ⅳ ( Col4) were performed to observe the degree of liver fibrosis and collagen deposition; qRT-PCR, immunohistochemistry, and Western blot were used to measure the expression of transforming growth factor-β1 ( TGF-β1) , PTEN, and downstream genes AKT, mTOR, and p70 S6 K. A one-way analysis of variance was used for comparison of continuous data between multiple groups and the least significant difference t-test was used for further comparison between any two groups. Results In the liver fibrosis group, liver pathology showed perisinusoidal fibrosis and fibrous tissue proliferation, collagen deposition, and formation of fibrous septum in the portal area; compared with the control group, the liver fibrosis group had significant increases in the mRNA and protein expression of TGF-β1, a significant reduction in the expression of PTEN, and significant increases in the mRNA and phosphorylated protein expression of AKT, mTOR, and p70 S6 K ( all P < 0. 01) . The qi-tonifying and blood-activating prescription group had a marked improvement in liver fibrosis; compared with the liver fibrosis group, the qi-tonifying and blood-activating prescription group had a significant increase in the expression of PTEN ( P < 0. 01) , significantly inhibited mRNA and protein expression of TGF-β1 ( both P < 0. 05) , and significant reductions in the mRNA and phosphorylated protein expression of AKT, mTOR, and p70 S6 K ( all P < 0. 05) . Conclusion Qi-tonifying and blood-activating prescription can prevent and reverse liver fibrosis, possibly by regulating the expression of PTEN and its downstream signal factors.
[1]ZHOU WC, ZHANG QB, QIAO L, et al.Pathogenesis of liver cirrhosis[J].World J Gastroenterol, 2014, 20 (23) :7312-7324.
|
[2]ARRIAZU E, RUIZ de GALARRETA M, CUBERO FJ, et al.Extracellular matrix and liver disease[J].Antioxid Redox Signal, 2014, 21 (7) :1078-1097.
|
[3]FRIEDMAN SL.Hepatic stellate cells:protean, multifunctional, and enigmatic cells of the liver[J].Physiol Rev, 2008, 88 (1) :125-172.
|
[4]ZHANG JQ, HAO LS.The research progress of PTEN in liver fibrosis diseases[J/CD].J World Latest Med Inf:Electronic Version, 2016, 16 (14) :83-85, 88. (in Chinese) 张家琪, 郝礼森.PTEN在肝纤维化疾病中的研究进展[J/CD].世界最新医学信息文摘:连续型电子期刊, 2016, 16 (14) :83-85, 88.
|
[5]AN J, ZHENG L, XIE S, et al.Regulatory effects and mechanism of adenovirus-mediated PTEN gene on hepatic stellate cells[J].Dig Dis Sc, 2016, 61 (4) :1107-1120.
|
[6]ZHAO XY, WANG BE, LI XM, et al.Newly proposed fibrosis staging criterion for assessing carbon tetrachloride-and albumin complex-induced liver fibrosis in rodents[J].Pathol Int, 2008, 58 (9) :580-588.
|
[7]WANG Q, WEN R, LIN Q, et al.Wogonoside shows antifibrotic effects in an experimental regression model of hepatic fibrosis[J].Dig Dis Sci, 2015, 60 (11) :3329-3339.
|
[8]SHEN GW, LI Q, LIU Y.Danji Huoxue decoction on serum inflammatory and liver fibrosis degradation indexes in hepatitis B patients with cirrhosis[J].J Changchun Univ Chin Med, 2016, 32 (6) :1188-1190. (in Chinese) 申广文, 李强, 刘颖.丹鸡活血汤对乙型肝炎肝硬化患者血清炎症指标及肝纤维化降解指标的影响[J].长春中医药大学学报, 2016, 32 (6) :1188-1190.
|
[9]SFERRA R, VETUSCHI A, CATITTI V, et al.Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation[J].Eur Rev Med Pharmacol Sci, 2012, 16 (11) :1484-1498.
|
[10]LI J, YE J, XUE DY, et al.Study on inhibition and mechanism of Guizhi Fuling Wan on hepatic fibrosis rats[J].Chin J Exp Med Formul, 2011, 17 (24) :171-175. (in Chinese) 李季, 叶军, 薛冬英, 等.桂枝茯苓丸抗大鼠肝纤维化作用及其机制研究[J].中国实验方剂学杂志, 2011, 17 (24) :171-175.
|
[11]ZHOU YX, CHEN J, LI JP, et al.Chinese medicinal herbs in treating model rats with hepatic fibrosis[J].Afr J Tradit Complement Altern Med, 2009, 7 (2) :104-108.
|
[12]KIM HG, HAN JM, LEE JS, et al.Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines[J].Sci Rep, 2015, 5:14531.
|
[13]WANG BY, ZHAO W, NIU XM, et al.Mechanism of action of Yiqi Huoxue Recipe in regulating autophagy and reversing liver fibrosis[J].Chin J Hepatol, 2017, 25 (5) :365-370. (in Chinese) 王宝玉, 赵文, 牛学敏.等.益气活血方调节自噬及逆转肝纤维化机制的研究[J].中华肝脏病杂志, 2017, 25 (5) :365-370.
|
[14]TAKASHIMA M, PARSONS CJ, IKEJIMA K, et al.The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation[J].J Gastroenterol, 2009, 44 (8) :847-855.
|
[15]NIU X, FU N, DU J, et al.miR-1273g-3p modulates activation and apoptosis of hepatic stellate cells by directly targeting PTEN in HCV-related liver fibrosis[J].FEBS Lett, 2016, 590 (16) :2709-2724.
|
[16]HAO LS, ZHANG XL, REN CZ, et al.Overexpression of thetumor suppressor gene PTEN inhibits the phosphorylation of Akt in activated hepatic stellate cells in vitro[J].J Pract Med, 2014, 30 (7) :1069-1072. (in Chinese) 郝礼森, 张晓岚, 任昌镇, 等.PTEN过表达抑制体外活化肝星状细胞Akt的磷酸化[J].实用医学杂志, 2014, 30 (7) :1069-1072.
|
[17]MATSUDA S, KOBAYASHI M, KITAGISHI Y.Roles for PI3K/AKT/PTEN pathway in cell signaling of nonalcoholic fatty liver disease[J].ISRN Endocrinol, 2013, 2013:472432.
|
[18]BIAN EB, HUANG C, MA TT, et al.DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats[J].Toxicol Appl Pharmacol, 2012, 264 (1) :13-22.
|
[19]LI WX, CHEN X, YANG Y, et al.Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway[J].Toxicology, 2017, 381:75-86.
|
[20]PERL A.mT OR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging[J].Ann N Y Acad Sci, 2015, 1346 (1) :33-44.
|
[21]WU CH, SHEN M, LI L, et al.Assocciation between PI3K/Akt/mT OR/p70S6K signaling pathway and hepatic fibrosis[J].J ClinHepatol, 2015, 31 (11) :1928-1932. (in Chinese) 吴长会, 沈敏, 李龙, 等.PI3K/Akt/mT OR/p70S6K信号通路在肝纤维化发生发展中的作用[J].临床肝胆病杂志, 2015, 31 (11) :1928-1932.
|
[22]ZHAN SX, HUANG C, MA TT, et al.The study on the effect of silencing p70S6K on the proliferation and activation of HSC-T6[J].Acta Univ Med Anhui, 2014, 49 (8) :1062-1067. (in Chinese) 占书箱, 黄成, 马陶陶, 等.抑制p70S6K对HSC-T6增殖活化的作用研究[J].安徽医科大学学报, 2014, 49 (8) :1062-1067.
|